On ECHEMI
Home > Drugs > Tuberous sclerosis complex
Tuberous sclerosis complex
Tuberous sclerosis complex is a hereditary disease characterized by facial sebaceous adenomas, epileptic seizures, and intellectual disability.
  • Site of disease:

    whole body
  • Infectious :

    Not contagious
  • Frequent population:

    The disease occurs in childhood and is more common in boys than in girls.
  • Related symptoms:

    papules epilepsy and epileptic seizures postictal mental disorder retinal hemorrhage secondary optic atrophy
  • Concurrent disease:

Related Drugs
Crane Toad Slices
Manufacturer:

Guangzhou Baiyunshan ZHONGYI Pharmaceutical Company Limited

Adapalene gel
Indication: This product is suitable for the treatment of common acne with acne, papules and pustules as the main manifestations. It can also be used to treat acne on the face, chest and back.
Manufacturer:

Heilongjiang Fuhe Pharmaceutical Group Co., Ltd.

EPIDIOLEX- cannabidiol_solution
Indication: EPIDIOLEX is indicated for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS), Dravet syndrome (DS), or tuberous sclerosis complex (TSC) in patients 1 year of age and older. EPIDIOLEX is indicated for the treatment of seizures associated with Lennox-Gastaut syndrome, Dravet syndrome, or tuberous sclerosis complex in patients 1 year of age and older ( 1.
Manufacturer:

Jazz Pharmaceuticals, Inc.

EPIDIOLEX- cannabidiol_solution
Indication: EPIDIOLEX is indicated for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS), Dravet syndrome (DS), or tuberous sclerosis complex (TSC) in patients 1 year of age and older. EPIDIOLEX is indicated for the treatment of seizures associated with Lennox-Gastaut syndrome, Dravet syndrome, or tuberous sclerosis complex in patients 1 year of age and older ( 1.
Manufacturer:

Jazz Pharmaceuticals, Inc.

Related Ingredients
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.